{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/60fe887cbd0207001bbbcd71/662120f6f7dc6900120081f7?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Wegovy, weight loss and pharmaceuticals: In sickness and in wealth","description":"<p>In this week's episode, Susannah and Sarah look at how the pharmaceutical sector is faring after a whirlwind few years. Exploring weight loss treatments, AstraZeneca, Novo Nordisk, GSK, and falling healthy life expectancy, find out how all of this could affect your savings and investments.</p><p><br></p><p>This podcast isn’t personal advice. If you’re not sure what’s right for you seek advice. Investments rise and fall in value, so investors could make a loss.</p>","author_name":"Hargreaves Lansdown"}